The problem is you can't risk your health. When buying a product you can risk a "clever" company that sells you a subpar product, but you can't really risk a "clever" pharmaceutical that sells you a subpar medicine or service.
The problem is you can't risk your health. When buying a product you can risk a "clever" company that sells you a subpar product, but you can't really risk a "clever" pharmaceutical that sells you a subpar medicine or service.
In a competitive market when people aren't happy with a product or service they take their business elsewhere. Over time companies with bad intentions get weeded out or never get off the ground.
Lots of conditions only have a single drug, and for some classes of pharmaceuticals big pharma has exited entirely (antibiotics)
I'm from Canada, so actually I am.
> In a competitive market ...
Doesn't apply to healthcare. Try shopping around for a trauma hospital after a car accident.
Yes, it absolutely does. The vast majority of 'healthcare' is operationally mundane, and not hyper-specialized such as those who are in car accidents might require.
Most public systems are quite inefficient, and without any possible market pressures (Canada healthcare act makes it technically illegal to sell healthcare services that are provided by the gov.) then those inefficiencies sink in.
Because there's a weird inelastic demand for certain services, pure market-oriented solutions won't work for 'car crashes' but they definitely could for most other things.
Walmart taking on healthcare is a very meaningful event, they could feasibly operationalize the more mundane issues to the point wherein it's the cheapest in the world for such services. This is hugely positive news.
I ask not to engage in a debate or to try to change your mind. I won't respond to anything you write. I'm just curious about people who don't advocate for universal healthcare what their reasoning is.
For the record, I think everyone should have access to the healthcare system and that no one should profit by denying a person care. I also don't think that being rich ought to grant you better access or quicker access to the system since resources are limited and the type of care or quickness or care should not be influenced by money.
Having better outcomes than the other for-profit pharma down the street, thus more customers, thus more money. Of course, if there is no competition at all then the incentives change, but this is not (yet?) the case.